Showing results (41-50 of 2,634) with videos related to
Sort By:
Pageof 264
Cancer|September 1, 1993
Daily alternating administration of high-dose alpha-2b-interferon and interleukin-2 bolus infusion in metastatic renal cell cancer. A phase II studyL Bergmann, K Fenchel, E Weidmann, et al.HNO|February 1, 1987
[Chemotherapy or chemotherapy and radiotherapy in advanced head and neck tumors. A prospective, randomized study comparing the 2 therapeutic modalities]A Klima, C von Ilberg, L Bergmann, et al.Respiration; International Review of Thoracic Diseases|January 1, 1985
Prognostic value of chest radiograph, serum-angiotensin-converting enzyme and T helper cell count in blood and in bronchoalveolar lavage of patients with pulmonary sarcoidosisM Rust, L Bergmann, T Kühn, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 16, 2002
Bendamustine is effective in relapsed or refractory aggressive non-Hodgkin's lymphomaE Weidmann, S-Z Kim, A Rost, et al.Leukemia & Lymphoma|May 9, 2001
Changing incidence and survival in patients with aids-related non-Hodgkin's lymphomas in the era of highly active antiretroviral therapy (HAART)K U Chow, P S Mitrou, K Geduldig, et al.Onkologie|December 1, 1983
[Results of drug therapy of inoperable non-small cell lung carcinoma with VP 16-213 (Etoposide) and cis-platin. A phase II study]T Klippstein, M Graubner, W E Berdel, et al.Haematologica|June 19, 2001
In vitro induction of apoptosis of neoplastic cells in low-grade non-Hodgkin's lymphomas using combinations of established cytotoxic drugs with bendamustineK U Chow, S Boehrer, K Geduldig, et al.European Journal of Cancer & Clinical Oncology|March 1, 1984
cis-Platinum (DDP) and VP 16-213 (etoposide) combination chemotherapy for advanced non-small cell lung cancer. A phase II clinical trialP S Mitrou, M Graubner, W E Berdel, et al.Leukemia Research|February 1, 1995
Bone marrow-derived T-cell clones obtained from untreated acute myelocytic leukemia exhibit blast directed autologous cytotoxicityB Jahn, L Bergmann, E Weidmann, et al.Leukemia & Lymphoma|August 1, 1995
Clinical experience with fludarabine and its immunosuppressive effects in pretreated chronic lymphocytic leukemias and low-grade lymphomasK Fenchel, L Bergmann, P Wijermans, et al.Pageof 264